Cerebrospinal fluid biomarker candidates for parkinsonian disorders
The parkinsonian disorders are a large group of neurodegenerative diseases including idiopathic Parkinson's disease (PD) and atypical parkinsonian disorders, such as multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, and dementia with Lewy bodies. The etiology o...
Main Authors: | Radu eConstantinescu, Stefania eMondello |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2012.00187/full |
Similar Items
-
Elevated Neurofilament Light Chain in Cerebrospinal Fluid and Plasma Reflect Inflammatory MRI Activity in Neurosarcoidosis
by: Keld-Erik Byg, et al.
Published: (2021-02-01) -
Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease
by: Fabian Maass, et al.
Published: (2020-02-01) -
NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration
by: Anthony Brureau, et al.
Published: (2017-08-01) -
Cerebrospinal Fluid Biomarkers in Parkinson’s Disease: A Critical Overview of the Literature and Meta-Analyses
by: Takayuki Katayama, et al.
Published: (2020-07-01) -
Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes
by: C. Starhof, et al.
Published: (2018-11-01)